The striatum is the major afferent component of the basal ganglia (Albin et al., 1989; Alexander and Crutcher, 1990; Graybiel, 1990; Gerfen, 1992) and receives dense excitatory, presumably glutamatergic projections from neocortex (Divac et al., 1977; Kim et al., 1977; McGeer et al., 1977) and thalamus (DubC et al., 1988; Lapper and Bolam, 1992) . Excitatory amino acid (EAA) binding sites are present in high densities in neostriatum; binding sites for the N-methyl-D-aspartate (NMDA) subtype of EAA receptors are particularly abundant (Monaghan et al., 1989; Sakurai et al., 1993) . Besides their physiological role in synaptic neurotransmission (Cherubini et al., 1988; Calabresi et al., 1992; Young and Bradford, 1993 ) NMDA receptors have been demonstrated to mediate excitotoxic effects. In striatum, injection of quinolinic acid, a NMDA receptor agonist, leads to loss of striatal GABA-ergic projection neurons with relative sparing of somatostatin-positive (Beal et al., 1986 (Beal et al., , 1989 (Beal et al., , 1991 Roberts et al., 1993) and cholinergic interneurons (Schwartz et al., 1983; Davies and Roberts, 1987; Boegman and Parent, 1988; Roberts and DiFiglia, 1989) .
Recent studies have disclosed that the NMDA receptor, like other ligand-gated ion channels, is composed of several protein subunits. Two families of subunits have been identified in the rat (Moriyoshi et al., 1991; Monyer et al., 1992; Ishii et al., 1993) . NMDARl subunits are encoded by a single gene containing 22 exons (Hollmann et al., 1993) ; three of these exons may be alternatively spliced, giving rise to a total of eight isoforms ( Fig. 1 ; terminology as in Durand et al., 1993) with distinct structural and pharmacological properties (Durand et al., 1992 (Durand et al., , 1993 Nakanishi et al., 1992; Sugihara et al., 1992; Hollmann et al., 1993) . NMDAR2 subunits are encoded by four distinct genes (NMDAR2A-D).
Although the exact structure and stoichiometry of native NMDA receptor channels is unknown, it is believed that they are assembled as hetero-oligomeric complexes composed of four or five subunits. In vitro, the presence of at least one NMDARl subunit is required to form a functional channel, and combinations of different NMDARl and NMDAR2 subunits give rise to receptors with different biochemical and pharmacological
properties. An analysis of the expression of NMDA receptor subunit mRNAs in rat basal ganglia demonstrated regionally restricted expression of NMDARl isoforms and NMDAR2 subunits (Standaert et al., 1993 (Standaert et al., , 1994 . These data indicated that each of the structures comprising the basal ganglia expresses a limited and distinct subset of NMDA receptor subunits. We hypothesized that NMDA receptor subunits and splice variants might be differentially expressed not only regionally but also at a cellular level in neurochemically identified striatal subpopulations. We focused our study on possible differences between striatal interneurons and striatal projection neurons because of the important and distinct roles of these cell types in striatal function and be- Shaded areas indicate the putative signal peptide region and the four predicted transmembrane domains (I-IV). The NMDARl gene consists of 22 exons; the isoforms arise from alternative splicing of exon 5 and 21 and use of an alternative splice acceptor site in exon 22. The alternatively spliced exons encode a 21 amino acid sequence in the amino-terminal domain of NMDARl (termed Nl following Durand et al., 1993 ; solid shading) and adjacent sequences of 37 and 38 amino acids in the carboxy-terminal domain (Cl and C2). Splicing out of exon 22 removes a stop codon present in the major isoform of NMDARI and generates a novel carboxy-terminal sequence of 22 amino acids (diagonal shading). Specific isoforms are indicated with subscripts marking the presence (I) or absence (0) of the three alternatively spliced exons in 5' to 3' direction as suggested by Durand et al. (1993) . The position of the four NMDARl probes used in this study are indicated by the dashes numbered 14.
cause NMDA agonists lead to selective damage to striatal projection neurons while sparing interneurons.
Materials and Methods
Animal tissues. All tissue was from adult male Sprague-Dawley rats (Charles River, 250-350 gm), killed by rapid decapitation. Brains were removed, frozen in isopentane, and stored at -70°C. Cryostat sections (12 urn) were cut in the coronal plane between rostra1 striatum and anterior commissure, mounted on poly-L-lysine slides (two sections per slide), and stored at -70°C until use. Tissues from three animals were used for each NMDA receptor probe. A series of 30 regularly spaced slides (10 slides per animal) were collected for hybridization with one receptor probe; all slides forming one series were processed in parallel, thus minimizing interslide variability.
Hybridization probes. The hybridization probes used in this study have been described and characterized previously (Standaert et al., 1994; Testa et al., 1995) . In brief, oligodeoxyribonucleotide probes 38 48 bases in length were made according to published cDNA sequences for the NMDARl and NMDAR2 receptor families as well as for acetylcholinesterase (AChE) (Legay et al., 1993) , choline acetyltransferase (ChAT) (Ishii et al., 1990; Vilaro et al., 1992) , preproenkephalin A (enkephalin) (Howells et al., 1984; Yoshikawa et al., 1984; Young and Kuhar, 1986) , and preprosomatostatin (somatostatin) (Goodman et al., 1982; Fitzpatrick et al., 1988) (Table 1 ). All probes except the probes 24 for NMDARl were directed to a cDNA area common to all reported splice variants. Probes had GC contents of 49-65%. No significant homologies to known sequences other than each probe's target were found on a search of the Genebank and EMBL databases (Altschul et al., 1990) .
Probes were synthesized on an Applied Biosystems 392 Synthesizer and purified by gel electrophoresis as previously described (Standaert et al., 1994; Testa et al., 1995) . Probes were 3'-end labeled with terminal deoxynucleotidyl transferase using either 35S(a)-dATP (DuPont-NEN, > 1000 Ci/mM) and a DuPont-NEN kit (NEP 100) for labeling and purification or digoxigenin-1 1-dUTP/cold dATP and a Genius 6 System kit (Boehringer). For the digoxigenin labeling, a molar ratio of 1 digoxigenin-1 1-dUTP to 10 dATP was employed. Digoxigenin-labeled probes were purified by ethanol precipitation and tested for labeling by blotting of serial dilutions of labeled probe onto nitrocellulose, immunohistochemical detection, and comparison of spot intensities with those of the control-labeled oligonucleotide provided in the labeling kit. i5S-labeled probes were stored at -70°C and used within 1 week of labeling. Digoxigenin labeled probes were stored at -20°C and used within 6 months of labeling.
Specz$city of NMDA receptor hybridization probes. The specificity of the probes used was tested as described previously (Standaert et al., 1994) . For all probes, competition with excess (25X) unlabeled probe abolished the signal. The hybridization pattern obtained with the respective probes was in agreement with previous published reports, as described in detail (Standaert et al., 1994) .
Specijcity and sensitivity of digoxigenin labeled probes. When probes were used in digoxigenin in situ hybridization experiments they yielded distributions identical to those observed after isotopic in situ hybridization, but with lower signal levels. Because of the limited sensitivity of digoxigenin in situ hybridization only neurons that were strongly labeled by isotopic probes were readily detected with digoxigenin-labeled probes. As reported by Testa et al. (I 995) digoxigeninenkephalin probe signal was consistently observed over cells in striatum and olfactory tubercle but not resolved in cerebral cortex. The number, size, and distribution of enkephalin-positive cells in the striatum on single-label digoxigenin in situ processed slides appeared the same as on single label isotopic in situ slides using the same probe. Similarly, digoxigenin-somatostatin and AChE probes consistently labeled cell populations comparable to those observed using radiolabeled somatostatin and AChE or ChAT probes, respectively.
Specificity of labeling with the neurochemical marker probes was further tested using pair-wise analysis of probes in the double-label in situ protocol on coronal sections through the striatum, as reported (Testa et al., 1995) . Double-label in situ hybridization with isotopic ChAT and digoxigenin-AChE probes produced a complete overlap of alkaline phosphatase-positive neurons and radiolabeled neurons, while no colocalization of alkaline phosphatase and radiolabeling was observed when AChE probes were combined with any of the other markers including somatostatin and parvalbumin probes (Testa et al., 1995) . Neurons labeled with digoxigenin-somatostatin probes were never observed to be radiolabeled for enkephalin, substance P, ChAT, or parvalbumin mRNAs. Similarly, digoxigenin-enkephalin probes labeled a population of striatal neurons that were distinct from those radiolabeled with substance P ChAT, parvalbumin, or somatostatin probes. Double label in situ hybridization histochemistry. Combined isotopic and nonisotopic hybridization was carried out as described (Testa et al., 1995) . Briefly, the double-label protocol is a modification of the method of Normand and Bloch (1991) . Isotopic in situ hybridization, emulsion dipping, and development is followed by a second hybridization using a digoxigenin-labeled probe through the emulsion, digoxigenin detection by an alkaline phosphatase tagged anti-digoxigenin antibody, and visualization of alkaline phosphatase activity. Sections for double-label in situ were first subjected to an isotopic in situ hybridization procedure as described (Standaert et al., 1994) . In short, for prehybridization, slides were placed in 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 (10 min): 3X PBS (5 min); 0.1 M triethanolamine, pH 8.0 with b.25% acetic anhydride (16 min); PBS (5 min); and graded ethanol solutions (2 min). Hvbridization was nerformed in a buffer of 50% formamide, 0.3 h N&J, 10 mM Tris, pH 8.0, 1 mM EDTA, pH 8.0, 10% dextran sulfate, 1 X Denhardt's solution (Sigma), 100 mM dithiothreitol, and approximately 30,000 dpm/pl of labeled probe at 37°C overnight. Cold competition controls were hybridized with a 25-fold excess of unlabeled probe added to the hybridization buffer. Prehybridization and hybridization solutions were treated with diethylpyrocarbonate (DEPC). Posthybridization washes were performed to a maximum stringency of 0.5X SSC at 60°C. Air-dried sections were then CTT GGG TCC GCG CTT GTT GTC ATA GGA CAG TTG GTC GAG GTT TTC Probe 3
CGT GTC TTT GGA GGA CCT ACG TCT CTT GAA GCT GGA GGC CAG GGT Probe 4
TAT GAC GGG AAC ACA GCT GCA GCT GGC CCT CCT CCC TCT CAA TAG NMDAR2A AGA AGG CCC GTG GGA GCT TTC CCT TTG GCT AAG TTT C NMDAR2B
CAT GTT CTT GGC CGT GCG GAG CAA GCG TAG GAT GTT GGA GTG GGT NMDAR2C
CCA GGT TTC TTG CCC TTG GTG AGG TTC TGG TTG TAG CT NMDAR2D CTG TGG CTC GAT GGG GCC GTA GTA TCG GTG GAA GCC GTC GGC TAT AChE Probe 1 CCC ATA GAT CCA GAT GAG GAC AGG TGT GGG AGA AGT AGG CCT GGG GTA Probe 2 AGG CAG CAC ATG CCA CTC GTG GTC CAC CAG GTC CTG AGC GGG CCT TGT Enkephalin ATC TGC ATC CTT CTT CAT GAA ACC GCC ATA CCT CTT GGC AAG GAT CTC Somatostatin GGA TGT GAA TGT CTT CCA GAA GAA GTT CTT GCA GCC AGC dipped in NTB2 liquid emulsion (Kodak, 1:l with distilled water), air dried, and stored with a desiccant in a light-tight box for 3 months at 4°C developed with D19 (Kodak, 1: 1 with distilled water; 14"C), fixed, and rinsed in distilled water for 2 min. After development and the final distilled water rinse, slides were rinsed with Permawash clearing agent (Heico Chemicals, Inc.) (5 min), DEPC-treated water (15 min), and twice in DEPC-treated PBS (15 min each). Slides were then incubated in a solution of DEPC-treated 4X SSC, 1% sarcosyl (Fisher) and 1 X Denhardt's solution (Sigma) (30 min) and dehydrated through graded ethanols (2 min each) and stored desiccated at 4°C until further use. Nonisotopic hybridization was performed in the same buffer as the isotopic hybridization except for omission of dithiothreitol, increased salt to 0.6 M NaCl, and addition of 2 ng/lOO p,l digoxigenin tailed probe in place of isotopic probe. All posthybridization steps were carried out at room temperature. Slides were dipped in 1 X SSC, rinsed in 1 X SSC (60 min), 1X SSC (60 min), and 0.3X SSC (60 min). For digoxigenin detection, slides were placed in 100 mM Tris-HCl, pH 7.5, 0.9% NaCl (buffer I) for 5 min, buffer I plus 3% normal goat serum (NGS), and 0.3% Triton X-100 (buffer II) for 30 min, and three rinses of buffer I (5 min each). Slides were incubated with alkaline-phosphatase-labeled anti-digoxigenin AB fragments (Boehringer), 1:500 in buffer I, 3% NGS, for 5 hr, then rinsed twice in buffer I (10 min each), 100 mM Tris-HCl, pH 7.5, 100 mM NaCl, 50 mM MgCl,, pH 9.5 (buffer III, 5 min), incubated overnight in the dark in buffer III with 337.5 mg/ml 4-nitroblue tetrazolium chloride 1NBT 75 mu/ml in 70% (v/v) dimethylformamide, Boehringer] and '175 mg/ml z-bromo-4-chloro-3-indolyl-phosphate (BCIE 50 mg/ml in 100% dimethylformamide, Boehringer), rinsed twice in buffer III (5 min each), dipped in water and 70% ethanol, air dried, and embedded in aqueous mounting medium (Gelmount, Biomedia Corporation). Double-labeling experiments were performed on two independent sets of radiolabeled slides, both of which produced identical results. Quantitative analysis. Emulsion silver grains (isotopic probes) and alkaline phosphatase reaction product (digoxigenin probes) were visualized under bright-field illumination using a 100X water immersion lens (Leitz). Quantitative assessment of NMDA receptor gene expression in specific cell types was accomplished by measurement of grain densities over alkaline phosphatase stained cell bodies (digoxigeninlabeled neuronal subpopulation marker probes) in the neostriatum and cortex. For each digoxigenin probe, both right and left striata on six sections (two from each of three animals) were analyzed. For somatostatin and acetylcholinesterase digoxigenin probe-labeled sections, all alkaline phosphatase-stained cells in the neostriatum dorsal to the anterior commissure were analyzed. For digoxigenin-enkephalin sections, 50 alkaline phosphatase-stained cells were analyzed in adjacent 100X fields in the dorsolateral striatum. A computer-assisted quantitative image analysis system (Imaging Research, Inc., St. Catharines, Ontario) was used to define the borders of each neuron, measure the cross-sectional area of the neuronal profile in square microns, and enumerate the silver grains overlying the cross-sectional area of alkaline phosphatasestained cells. Since neurons-in particular, large ones-were only partially contained within the 12 pm tissue sections, the intensity of the hybridization signal per cell (as indicated by the number of silver grains) could not be easily determined. Instead, the total number of grains and the area of profile of each neuron were used to calculate the number of grains per 1000 pm2 of neuronal area, as a measure of the density of mRNA per unit volume of neuronal cytoplasm. This denominator allows for a more direct comparison of cellular levels of mRNA expression between cells of different size and corrects for partial sections through cells. Background labeling was determined by counting silver grains next to the tissue sections; a mask corresponding to the mean cross-sectional area of the neuronal populations examined was used for sampling. The distributions of grain densities for each neuronal population and for background were compared using an ANOVA analysis in combination with a post hoc test for multiple comparisons (Scheffe or Bonferroni-Dunnett) provided on a commercial statistics software package (STATVIEW 4.01, Abacus Concepts Inc.).
Results
Expression of NMDA receptor subunit mRNAs in striatum
Single-label in situ hybridization using film and emulsion autoradiograms were examined to explore the overall striatal distribution of NMDA receptor subunits. At the level of film autoradiograms the probes recognizing all NMDARl isoforms ("probe 1"; see Fig. 1 ) and those recognizing the alternatively spliced regions coding for the carboxy-terminal segments Cl and C2 ("probes 3 and 4") resulted in high and moderate striatal Signals obtained with the NMDAR2A probes displayed a lateromedial (and a less marked rostrocaudal) decreasing gradient resulting in a less intensely labeled medio-ventro-caudal core region within the striatum. Hybridization signals with the NMDAR2B probe appeared homogeneous throughout the striatum.
Inspection of emulsion autoradiograms following hybridization with the NMDARl probe 1 showed accumulations of silver grains over both medium-sized and large polygonal neurons; no cells with unambiguous neuronal morphology lacking labeling with probe 1 were seen. Hybridization with NMDARI probe 2 resulted in low numbers of grains over striatal neurons similar to the labeling observed over white matter regions (e.g., corpus callosum) and was therefore regarded as nonspecific. NMDARl probe 3, in contrast, labeled most striatal neurons. The pattern of labeling with NMDARl probe 4 was similar to that produced by probe 1. Microscopic examination of the striatum following hybridization with probe NMDAR2A disclosed a uniform appearing accumulation of silver grains over all striatal neurons examined; the gradient of intensity observed on film autoradiograms with more intense labeling laterally and dorsally was related to differences in the intensity of labeling per cell rather than to the number of labeled cells. Hybridization with the NMDAR2B probe resulted in a more intense labeling of striatal neurons, which was relatively uniform. No neuronal labeling was observed with the NMDAR2C probe, but clusters of silver grains were found over a subpopulation of small cells with scant cytoplasm, most likely glial cells. Emulsion autoradiograms of sections hybridized with the NMDAR2D probe disclosed a small number of clearly labeled medium-sized and large striatal neurons.
Expression of NMDAR subtypes in identijed neurons NMDARI probe I. Double-label in situ hybridization with a radiolabeled probe common to all isoforms of NMDARl (probe 1) in combination with digoxigenin-labeled probes for enkephalin, somatostatin, or acetylcholinesterase, resulted in significant hybridization signals over all three striatal populations examined ( Fig. 2A ,C,E; background 7 2 I grains per 1000 pm2, p < 0.0001 by ANOVA). Visual inspection showed that all neurons labeled with the enkephalin probe exhibited significant numbers of silver grains ( Fig. 2A) , indicating the presence of NMDARl mRNA. The majority of neurons (> 80%) labeled with the somatostatin probe also gave signals with the NMDARl probe but appeared to be more lightly labeled (Fig. 2C) . Quantitative analysis by grain counting disclosed that the density of silver grains over somatostatin-positive neurons was, indeed, significantly lower than over enkephalin-positive neurons (59 ?. 5 vs 100 + 3.5 (mean ? SEM) grains per 1000 km*, p < 0.0001 by ANO-VA; Fig. 4 ). All neurons labeled with the digoxigenin-tagged acetylcholinesterase probe were clearly marked by silver grains (Fig. 2E ) but displayed significantly lower grain densities than enkephalin-positive neurons (67 + 3 vs 100 + 3.5 grains per 1000 pm*, p < 0.0001 by ANOVA; Fig. 4) . The difference in labeling density between the two striatal interneuron populations was not statistically significant. In the same sections, labeling of cortical somatostatin-positive neurons was observed. Compared to striatal somatostatin-containing neurons, neocortical somatostatin-positive neurons exhibited significantly higher grain densities following hybridization with probe 1 (p < 0.0001; ANO-VA, Fig. 5 ). NMDARI probe 2. Hybridization with probe 2, recognizing the region encoding the amino-terminal insertion Nl in NMDARI , resulted in no significant labeling in any striatal population examined. In contrast, most neocortical somatostatincontaining neurons were clearly labeled by this probe (Fig. 5) .
NMDARI probe 3. Hybridization with probe 3, recognizing the region encoding the first alternatively spliced carboxy-terminal cassette Cl, gave rise to a relatively intense labeling of enkephalin-positive neurons (78 2 3 grains per 1000 km'; Fig.  2B ). Approximately 90% of somatostatin-positive neurons displayed two grains or less per cell; there were no strongly labeled subpopulations (Fig. 20) . Most acetylcholinesterase-positive neurons appeared unlabeled or exhibited very low numbers of grains (Fig. 2F ). Mean grain densities over somatostatin-and acetylcholinesterase-positive neurons were significantly lower than over enkephalin-positive neurons (11 + 1.5 and 10 + 1 grains per 1000 p,m2; p < 0.0001 by ANOVA and Scheffk; Fig.  4 ). Since the mean background levels obtained with this probe were significantly lower (5 + 0.7 grains per 1000 pm*; p < 0.01 by ANOVA) we cannot exclude the presence of very low levels of NMDARI mRNA encoding the first alternatively spliced carboxy-terminal cassette Cl in somatostatin-and acetylcholinesterase-positive neurons. Similar to their striatal counterparts, neocortical somatostatin-positive neurons were practically devoid of hybridization signal for probe 3 (Fig. 5) .
NMDARI probe 4. Hybridization with probe 4, recognizing the region encoding the second alternatively spliced carboxyterminal cassette C2, resulted in labeling of most enkephalinpositive neurons. The majority of somatostatin-positive cells (60%) appeared to be unlabeled; however, a small percentage (< 10%) of somatostatin-positive cells displayed the same grain densities as enkephalin-positive neurons. Quantitative analysis demonstrated that the mean grain density of enkephalin-positive neurons was significantly higher than that of somatostatin-containing neurons (59 + 4 vs 22 -t 3 grains per 1000 p-m*, p < 0.0001 by ANOVA and Scheffk; Fig. 4 ). Acetylcholinesterasepositive neurons appeared to be uniformly labeled at relatively low levels. The grain density over putative cholinergic neurons (34 ? 2 grains per 1000 pm* ) was significantly lower than over enkephalin-positive neurons 0, < 0.0001 by ANOVA and Scheffk; Fig. 4 ) but was significantly higher than over somatostatin-containing neurons (p < 0.0053 by ANOVA and Scheffk; *, statistically significant differences 0, < 0.01) between enkephalin-positive neurons and the respective interneuron population. the mean densities observed over the three neuronal populations studied (9 & 1.3 grains per 1000 p,m2, p < 0.0001 by ANOVA). There was no difference in the level of hybridization signal for probe 4 in neocortical compared to striatal somatostatin-positive neurons (Fig. 5) .
NMDAR2A. A relatively weak hybridization signal with the probe for subunit NMDAR2A was associated all three striatal populations. Because of the relatively low maximum signal obtained with this probe in striatum it was difficult to separate labeled and unlabeled populations by visual inspection. Quantitative analysis disclosed no significant difference in labeling density between somatostatin-positive and enkephalin-positive neurons (18 ? 2 vs 23 t 2 grains per 1000 pmZ, p = 0.1566; NS by ANOVA; No significant labeling of any striatal neuronal population was observed following hybridization with the NMDAR2C probe. NMDAR2D.
After hybridization with the NMDAR2D probe, all enkephalin-positive neurons appeared unlabeled (< 2 grains per cell). Distinct labeling of moderate intensity was seen over almost all acetylcholinesterase-positive neurons and over at least 50% of somatostatin-positive neurons. Quantitative analysis confirmed the impression that enkephalin-positive neurons were unlabeled (2 + 0.4 grains per 1000 p,m*; mean background grain density 7 ? 0.8 grains per 1000 km') and disclosed a similar mean grain density for acetylcholinesteraseand somatostatin- positive neurons (27 + 3 and 29 -t 2 grains per 1000 pmZ). Simultaneous hybridization of both digoxigenin-labeled somatostatin and AChE probes on slides labeled with radioactive NMDAR2D probe indicate that some medium-sized striatal neurons labeled with the NMDAR2D probe were not identified by these digoxigenin-labeled probes. Scattered cortical neurons also displayed hybridization signals with NMDAR2D probes; the majority of cortical somatostatin-positive neurons appeared labeled.
Discussion
Using an in situ hybridization double-labeling technique, we have examined the expression of NMDA receptor subunit mRNAs in neurochemically identified striatal neurons and observed that enkephalin-positive striatal projection neurons express a different NMDA receptor phenotype than somatostatinpositive and cholinergic striatal interneurons. Enkephalin-positive neurons express NMDARl mRNA along with NMDAR2A and NMDAR2B mRNAs. Somatostatin-positive and putative cholinergic neurons contain in addition NMDAR2D
mRNA. Both populations of striatal interneurons examined express lower levels of NMDARl and NMDAR2B mRNA than enkephalinpositive neurons. Markers for alternatively spliced regions of NMDARl further indicated that all striatal neuronal populations examined express NMDARl isoforms lacking the amino-terminal alternatively spliced exon Nl (NMDARl,,,,; see Fig. 1 ). Enkephalin-positive neurons are enriched in an NMDARl splice form containing both alternatively spliced carboxy-terminal cassettes C 1 and C2 (NMDARl,, , ; see Fig. 1 ). In contrast, somatostatin-positive neurons display weak hybridization signals with probes for both Cl and C2, suggesting the presence of the isoform NMDARI,,,, while acetylcholinesterase-positive neurons show no signal for Cl but moderate signals for C2, suggesting the presence of NMDARI,,,,, (see Fig. 1 ).
Technical considerations
In order to determine the repertoire of NMDA receptor subunit mRNAs expressed in functionally distinct striatal neuron populations, it was necessary to develop an in situ double-labeling technique. Isotopically labeled oligodeoxynucleotide probes and emulsion autoradiography were used to detect and quantify receptor mRNAs in combination with digoxigenin-tagged oligodeoxynucleotide probes to identify mRNAs of neurochemical markers for striatal cell populations. The receptor oligonucleotide probes used have been shown to specifically recognize the intended mRNA targets in a highly reproducible fashion (Standaert et al., 1994) . In a similar way, hybridization with digoxigenin-tagged oligonucleotides complementary to neurochemical marker mRNAs results in a highly selective labeling of discrete, nonoverlapping neuronal populations (Testa et al., 1995) . Using this method, only striatal cells with large, oval, or multipolar cell bodies are labeled with the digoxigenin-labeled AChE probe; there is no overlap with isotopically identified somatostatin-and parvalbumin neurons (see Materials and Methods and Testa et al., 1995) , cell types known to contain AChE activity or protein (Levey et al., 1983; Bolam et al., 1984) although at lower levels than cholinergic neurons (Levey et al., 1983) , probably because of the limited sensitivity of digoxigenin-labeled oligonucleotide probes. Since the efficiency of hybridization of different probes as well as the relative preservation of different mRNAs during the tissue processing may vary, it is problematic to infer differences in mRNA levels per neuron from differences in hybridization signals obtained with dissimilar probes. However, provided the same probes are used, silver grain density can be used to compare the relative amounts of a particular mRNA between different neuronal populations, especially since slides were processed in parallel and every effort was made to ensure interslide uniformity of hybridization signal. Interslide variability was typically less than 15% of the mean grain density.
Phenotype of NMDAR subunit expression in striatal neurons Using a probe to a region common to all isoforms of NMDARl we observed quantitative differences in the expression of NMDARl between the striatal populations examined. Our finding of low levels of NMDARl mRNA in somatostatin-containing neurons is in agreement with a recent semiquantitative study (Augood et al., 1994) demonstrating a weak or undetectable in situ hybridization signal for NMDARl in striatal neurons labeled by alkaline phosphatase-tagged somatostatin antisense oligonucleotides. These data and our findings contradict suggestions by ) that striatal NADPH-diaphorase/NOS immunoreactive neurons (identical to SOM/NPY-containing neurons, Vincent et al., 1983; Kharazia et al., 1994) are enriched in NMDARl mRNA relative to neighboring neurons. The NMDARl probes employed in our study and that of Price et al. (1993) were targeted to regions of the NMDAR 1 mRNA common to all isoforms; the sequence of the probe used by Augood et al. (1994) was not specified. Price et al. (1993) employed a method involving Kodak NTB emulsion to quantify in situ hybridization signals with radioactive probes after development of an immunohistochemical chromogen, a procedure susceptible to chematographic artifacts (Young and Hsu, 1991; Dagerlind et al., 1992; G. B. Landwehrmeyer, unpublished observations) .
Beyond these quantitative differences, enkephalin-positive projection neurons differ from the interneurons examined by differential splicing of the mRNA encoding the carboxy-terminal sequences C 1 and C2 of NMDAR 1. In addition, the interneurons differ from each other in the extent of usage of the carboxyterminal splice cassette Cl. The weak or absent hybridization signals with probe 2 (recognizing Nl) in all identified striatal cell populations and the relatively strong signals with probes 3 and 4 (recognizing Cl and C2, respectively) in striatal enkephalin-positive neurons agree well with the striatal signals observed on film autoradiograms (Standaert et al., 1993 (Standaert et al., , 1994 . Together, the signals obtained with these probes suggest a predominant expression of the isoform NMDARl,,, , in enkephalinpositive neurons. The finding that an isoform containing both Cl and C2 is abundant in caudate-putamen (Laurie and Seeburg, 1994b ) supports this conclusion. In comparison, striatal somatostatin-positive neurons displayed no hybridization signals with probes 2 and 3 and low signals with probe 4, suggesting that somatostatin-positive neurons contain the isoform NMDARl,,,,,,. The sparse and scattered hybridization signals obtained in striaturn with a splice site spanning probe recognizing NMDARl.,,,, (Laurie and Seeburg, 1994b) agrees well with an expression of this isoform by a small subset of striatal neurons.
NMDAR2 subunit mRNAs were present in all striatal neuronal populations examined. NMDAR2B grain density was lower in both interneuron populations than in enkephalin-positive neurons and NMDAR2A density was lower in cholinergic neurons. The levels of NMDAR2 subunit mRNAs have to be viewed in context with the levels of NMDARl mRNA observed in the same cell population; under the assumption that the levels of NMDARl are roughly proportional to the number of NMDA channels (Augood et al., 1994) a proportional lower level of NMDAR2 mRNA in interneurons would have been predicted. Whether the essentially identical NMDAR2A hybridization signals and the relatively decreased NMDAR2B signals in somatostatin-positive neurons indicate a change in subunit stoichiometry is difficult to decide, since neurons may differ in mRNA turnover and translational efficiency.
NMDAR2D mRNA appears to be expressed almost exclusively by interneurons. Whereas all acetylcholinesterase-positive neurons were uniformly labeled, some somatostatin-positive neurons displayed low levels of labeling, suggesting that subgroups of somatostatin-positive neurons may exist with respect to NMDAR2D expression. This observation is in line with recent evidence suggesting that somatostatin-positive neurons in rat caudate-putamen may not form a homogeneous population (Vincent and von Krosigk, 1988; Rushlow et al., 1994) . Since somatostatin-and AChE-positive neurons together failed to account for all striatal NMDAR2D-positive neurons, an additional, small population of medium-sized striatal neurons, possibly parvalbumin-containing interneurons, may express NMDAR2D. This population of interneurons as well as the population of projection neurons expressing substance P were not included in the present analysis because of the limited sensitivity of digoxigenin-tagged oligonucleotide probes, and are presently being studied in our laboratory using digoxigenin-labeled RNA probes.
Functional properties of NMDA channels on striatal neurons mRNAs coding for NMDARl as well as for members of the NMDAR2 family were present in all striatal neurons examined. The relatively low levels of both NMDARl and NMDAR2 subunit mRNA in the two populations of interneurons suggests that these two types of striatal neurons exhibit a lower density of NMDA receptor channels compared to enkephalinergic projection neurons. The putative lower density of NMDA receptors might reflect the fact that these neurons receive fewer excitatory afferents (Aoki and Pickel, 1989; Lapper and Bolam, 1992) . The presence of both NMDAR2A and NMDAR2B mRNAs in enkephalin-containing neurons and of NMDAR2A, -2D (and 2B) mRNAs in cholinergic and somatostatin-containing neurons suggest that native NMDA receptor channels in these neurons are assembled from more than two subunits of the NMDAR2 family. This suggestion agrees with the observation that when three different NMDA receptor subunits are coexpressed in Xenopus oocytes a heteromeric receptor containing all subunits is preferentially formed (Wafford et al., 1993) . It is unknown whether cells expressing several NMDAR subunits form a homogenous population of NMDA channels composed out of all expressed subunits or heterogeneous populations with distinct combinations of subunits. Immunoprecipitation studies will help to clarify the subunit composition of NMDA receptor channels.
Several properties of recombinant NMDA receptors have been shown to be influenced by alternative splicing of NMDARl and the subunit composition'of NMDA receptors. Splicing at the carboxy-terminal region of NMDARl appears to regulate the sensitivity of the NMDARl subunit to protein phosphorylation (Tingley et al., 1993) and may, through this mechanism, modulate kinetic properties (Huganir and Greengard, 1990; Ben-Ari et al., 1992) and the subcellular distribution of the NMDARl protein (Tingley and Huginar, 1994) . Since cholinergic and somatostatin-containing interneurons express significantly lower levels of NMDARl mRNA containing the alternatively spliced carboxy-terminal regions than enkephalin-containing striatal projection neurons, NMDA receptors expressed in these two populations may differ in subcellular distribution and kinetic properties. Ligand binding properties are strongly influenced by subunit composition in heteromeric channels (Buller et al., 1994; Laurie and Seeburg, 1994a) . Since NMDARl-2B has glutamate agonist-preferring properties (Buller et al., 1994; Laurie and Seeburg, 1994a ) and the affinities of channel blockers are higher for NMDARl-2A/2B than for NMDARl-2C/2D (Laurie and Seeburg, 1994a) , one would predict that enkephalin-positive projection neurons display higher affinities for glutamate agonist and channel blockers than the interneurons studied. In addition, it has been suggested that NMDA receptors containing the subunits NMDAR2C or NMDAR2D have lower affinities for quinolinate (and homoquinolinate) than those containing NMDAR2A and NMDAR2B (Buller et al., 1994) . Striatal interneurons that express NMDAR2D may therefore have higher thresholds for the effects of the endogenous NMDA receptor agonist quinolinate.
Implications for exitotoxicity The differences in NMDA receptor phenotypes between projection neurons and interneurons may have important consequences not only for the modulation of striatal activity by glutamatergic afferents but also for the differential vulnerability of striatal neurons to excitotoxic injury. In striatum, injection of NMDA agonists leads to selective damage to striatal GABAergic projection neurons while relatively sparing somatostatin/neuropeptide Y/nitric oxide synthase-positive and cholinergic interneurons (Beal et al., 1986 (Beal et al., , 1991 Boegman and Parent, 1988; Davies and Roberts, 1988; Roberts and DiFiglia, 1989; Roberts et al., 1993) . Similar findings have been reported for cultured striatal (Koh and Choi, 1988) and cortical (Koh et al., 1986) neurons and for organotypic cultures (Whetsell and Schwartz, 1989) . This pattern of neuronal loss resembles the pathology of Huntington's disease (HD), an autosomal dominant neurodegenerative disorder characterized by a progressive loss of striatal neurons (Vonsattel et al., 1985) . In HD, medium-sized spiny striatal projection neurons expressing enkephalin, substance P, dynorphin, and GABA are preferentially affected. In contrast, the degeneration of medium-sized aspiny striatal interneurons containing SOM/ neuropeptide Y/NOS is less apparent, resulting in a relative preservation of somatostatin-containing and cholinergic interneurons (Dawbarn et al., 1985; Ferrante et al., 1985 Ferrante et al., , 1987 Beal et al., 1986) . The mechanisms underlying the differential patterns of neuronal vulnerability to HD or to NMDA-induced neurotoxicity are not known. One plausible mechanism would be that these distinct neuronal populations express different amounts or subtypes of NMDA receptors. The results of our study are compatible with this potential mechanism. Both the abundance and nature of NMDA receptors expressed by the relatively resistant population of somatostatin-containing and cholinergic interneurons differ from NMDA receptors expressed by the vulnerable population of enkephalin-positive neurons.
In order to study whether the pattern of NMDA receptor expression observed in striatal interneurons was unique to the striaturn or was also present in other neuronal populations, we explored the NMDA receptor phenotype of another neurochemitally identified neuronal population, somatostatin-containing cortical neurons. Somatostatin-containing cortical neurons are known to be GABAergic interneurons and are relatively resistant to NMDA toxicity (Koh et al., 1986; Boegman et al., 1987; Beal et al. * NMDA Receptors in Identified Striatal Neurons et al., 1991) and &hernia. In comparison to striatal somatostatin-containing neurons, neocortical somatostatin-containing neurons were characterized by higher levels of expression of NMDARl . Unlike striatal neurons, neocortical somatostatinpositive neurons exhibited hybridization signals with NMDARl probe 2, indicating the expression of an NMDARl isoform containing the amino-terminal region Nl . Hybridization signals with probes 3 and 4 for NMDARl as well as for the probes for the NMDAR2 family did not differ between striatal and neocortical somatostatin-positive neurons.
Although there does not appear to be a single NMDA receptor phenotype that characterizes all neurons resistant to excitotoxicity, our results suggest that differential expression of NMDA receptor subunit does, indeed, make a significant contribution to the relative vulnerability of striatal neurons. The expression pattern of other glutamate receptors (Martin et al., 1993; TallaksenGreene and Albin, 1994; Testa et al., 1995) , differences in intracellular Ca'+ handling including the expression of Ca2+-binding proteins (Sloviter, 1989) and cellular bioenergetic demands (Albin and Greenamyre, 1992; Beal, 1992) and other factors may act in concert with an unique expression pattern of NMDA receptors to determine cellular vulnerability or resistance. It is intriguing that both cortical and striatal somatostatin-containing neurons express NMDARl isoforms with carboxy-terminal deletions. Our findings raise the possibility that phosphorylation of the NMDARl receptors may play a role in determining the excitotoxic potential of NMDA receptors. Furthermore, the presence of NMDAR2D mRNA in striatal interneurons may result in the expression of NMDA receptors with low affinities to quinolinate and raise the thresholds for the neurotoxic effects of this endogenous NMDA receptor agonist. Further clarification of the role of NMDARl isoforms and of NMDA receptor subunit composition in excitotoxicity will require additional studies of recombinant receptors and potentially the use of antisense technologies to selectively suppress the expression of particular NMDA receptor subunits (Standaert et al., 1994) .
